Regeneron Pharmaceuticals Inc. buy BMO Capital Markets
Start price
05.02.24
/
50%
€858.00
Target price
05.02.25
€1,006.8
Performance (%)
-19.14%
End price
06.02.25
€693.80
Summary
This prediction ended on 06.02.25 with a price of €693.80. The price of Regeneron Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.14%. BMO_Capital_Markets has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. BMO_Capital_Markets has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.942% | 0.942% | 21.057% |
| iShares Core DAX® | 0,88 % | 1,05 % | 7,09 % |
| iShares Nasdaq 100 | 0,75 % | 4,66 % | 41,85 % |
| iShares Nikkei 225® | 5,52 % | 15,41 % | 73,76 % |
| iShares S&P 500 | 0,24 % | 1,68 % | 27,53 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at BMO Capital Markets from $1,055.00 to $1,082.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€494.10
04.08.25
04.08.25
€552.90
04.08.26
04.08.26
10.03%
14:08
14:08
Stopped prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€541.10
18.05.26
18.05.26
€628.24
18.05.27
18.05.27
-0.03%
14:08
14:08
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€625.20
04.12.25
04.12.25
€728.79
04.12.26
04.12.26
-13.33%
14:08
14:08
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€427.60
02.06.25
02.06.25
€527.70
02.06.26
02.06.26
20.00%
03.06.26
03.06.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€515.60
30.04.25
30.04.25
€703.60
30.04.26
30.04.26
15.46%
01.05.26
01.05.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€681.40
04.02.25
04.02.25
€869.77
04.02.26
04.02.26
-4.08%
05.02.26
05.02.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,096.8
01.11.25
01.11.25
-27.09%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€939.20
24.09.24
24.09.24
€1,165.3
24.09.25
24.09.25
-47.87%
25.09.25
25.09.25